Results 21 to 30 of about 42,599 (163)

The association of N-terminal pro-brain-type natriuretic peptide with hemodynamics and functional capacity in therapy-naive precapillary pulmonary hypertension: results from a cohort study

open access: yesBMC Pulmonary Medicine, 2017
Background N-terminal pro-brain-type natriuretic peptide (NT-proBNP) is currently used as a surrogate marker for disease severity in pulmonary hypertension (PH).
T. M. Berghaus   +4 more
doaj   +1 more source

NT-proBNP and Its Correlation with In-Hospital Mortality in the Very Elderly without an Admission Diagnosis of Heart Failure. [PDF]

open access: yesPLoS ONE, 2016
BACKGROUND:The diagnosis of heart failure (HF) is often difficult and underestimated in very elderly comorbid patients, especially when an echocardiographic evaluation is not available or feasible.
Riccardo Sarzani   +9 more
doaj   +1 more source

A Novel N-Terminal Pro-B-Type Natriuretic Peptide Assay in the Early Diagnosis of Acute Heart Failure

open access: yesJACC: Advances
Background: The performance of the novel NT-pro-B-type natriuretic peptide (NT-proBNP)-Access assay in the early diagnosis of acute heart failure (AHF) is unknown.
Maria Belkin, MD   +23 more
doaj   +1 more source

Molecular Pathways Linking Thyroid Dysfunction, NT-proBNP, and Cardiac Health: A Clinical and Biomarker-based Analysis [PDF]

open access: yesIndian Journal of Medical Biochemistry
Background: Thyroid hormones play a crucial role in cardiovascular function, influencing heart rate, vascular resistance, and myocardial contractility.
Jayesh Warade, Sunil A Chakole
doaj   +1 more source

Reference intervals for N-terminal pro-B-type natriuretic peptide in amniotic fluid between 10 and 34 weeks of gestation. [PDF]

open access: yesPLoS ONE, 2014
BACKGROUND: In adult and pediatric cardiology, n-terminal pro-B-type natriuretic peptide (nt-proBNP) serves as biomarker in the diagnosis and management of cardiovascular dysfunction.
Waltraut M Merz   +4 more
doaj   +1 more source

Can NT-proBNP Levels Be an Early Biomarker of Reduced Left Ventricular Ejection Fraction in Preterm Infants?

open access: yesChildren, 2022
Background/Objective: N-terminal pro-B-type natriuretic peptide (NT-proBNP) is a cardiac natriuretic hormone that cardiomyocytes release in response to ventricular stretch.
Ya-Lan Lin   +4 more
doaj   +1 more source

BRAIN NATRIURETIC PEPTIDE AS BIOCHEMICAL MARKER FOR STRUCTURAL AND FUNCTIONAL HEART DISORDERS IN ARTERIAL HYPERTENSION

open access: yesРоссийский кардиологический журнал, 2015
Aim. Assessment of structural and functional condition of the left and right heart chambers related to the level of NT-proBNP and clinical signs of CHD in AH patients.Material and methods.
S. V. Ivanova   +4 more
doaj   +1 more source

Prognostic Value of Admission Peak NT-proBNP Combined with Culprit Plaque Types for Predicting Cardiovascular Risk in ST-Segment Elevated Myocardial Infarction: An Optical Coherence Tomography Study

open access: yesJournal of Cardiovascular Development and Disease, 2022
Objective: Different culprit plaque phenotypes including plaque rupture (PR) and non-plaque rupture (NPR), and N-Terminal prohormone of brain natriuretic peptide (NT-proBNP) have been reported to influence clinical outcomes in patients with acute ...
Jiannan Li   +11 more
doaj   +1 more source

Body mass index modifies the major adverse cardiovascular and cerebral events risk of NT-proBNP in patients with acute coronary syndrome

open access: yesDiabetology & Metabolic Syndrome
Background Little is known about the relationship between body mass index (BMI) and the prognostic value of N-terminal pro-B-type natriuretic peptide (NT-proBNP) in patients with acute coronary syndrome (ACS).
Xiaoquan He   +5 more
doaj   +1 more source

Amino-Terminal Pro-Brain Natriuretic Peptid in Prediction of Left Ventricular Ejection Fraction

open access: yesBiomolecules & Biomedicine, 2008
We aimed to evaluate levels of amino-terminal pro-brain natriuretic peptid (NT-proBNP) in prediction of left ventricular ejection fraction (LVEF) in heart failure patients.
Mugdim Bajrić   +10 more
doaj   +1 more source

Home - About - Disclaimer - Privacy